Intranasal Ketamine Versus Intranasal Fentanyl

Brief Summary

Abstract Background: Given the inadequate control of pain in patients with injury that refer to the emergency departments, the rapid onset of action of intranasal administration in pain management, and the avoidance of administering opioid medications, the present study aimed at evaluating the effect of intranasal ketamine versus intranasal fentanyl on pain management in isolated traumatic patients Materials and Methods: The current study was performed on 125 patients that were divided into the following three groups: control group (n = 41), 1 mg/kg intranasal ketamine group (n = 40), and 1μg/kg intranasal fentanyl group (n = 44). Then pain scores, HR, RR, BP, and SaO2 were recorded at baseline, 5, 10, 15, 30, and 40 minutes after the intervention.

Intervention / Treatment

  • Drug: Placebo
  • Drug: Ketamine
  • Drug: Fentanyl

Condition or Disease

  • Multiple Trauma
  • Pain, Acute

Phase

Study Design

Study type: Interventional
Status: Completed
Study results: No Results Available
Age: 15 Years to 65 Years   (Child, Adult, Older Adult)
Enrollment: 125 ()
Funded by: Other

Masking

Clinical Trial Dates

Start date: Apr 01, 2017
Primary Completion: Mar 20, 2018
Completion Date: Apr 15, 2018
Study First Posted: Jun 04, 2020
Results First Posted: Aug 31, 2020
Last Updated: Jun 04, 2020

Sponsors / Collaborators

Lead Sponsor: N/A
Responsible Party: N/A

Location

Eligibility Criteria

Sex: All
Minimum Age: 15
Maximum Age: 65

More Details

NCT Number: NCT04414800
Other IDs: 396828
Study URL: https://ClinicalTrials.gov/show/NCT04414800
Last updated: Mar 18, 2021